About this trial
While mechanical ventilation can be used to sustain life in those with lung injury, it, can further worsen lung injury or prevent lung healing resulting in high morbidity and mortality as seen in Acute Respiratory Distress Syndrome (ARDS).
Using extracorporeal membrane oxygenation (ECMO), the highest level of life support also known as the heart-lung machine, investigators may minimize injury from mechanical ventilation to allow the lungs to heal; however, the optimal ventilator strategies while on ECMO are unknown. This study will evaluate personalized ventilator strategy compared to standard of care ventilation.
Eligibility criteria
Qualifiers
History of Lung or Cardiac Transplantation, or definite bridge to transplantation
Patient is not committed to full support
Treating clinician refusal, or unwillingness to commit to controlled therapeutics (Esophageal Pressure Guided Positive End-Expiratory Pressure and neuromuscular blockade)
Inability to get informed consent from the patient or legally authorized representative (LAR)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Personalized Positive End-Expiratory Pressure (PEEP)
Treatment groups
Sponsors and collaborators
University of California, San Diego
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator